6747

Brighten OptixTPEX:6747 Stock Report

Market Cap

NT$6.5b

7D

5.3%

1Y

77.5%

Updated

17 Sep, 2021

Data

Company Financials +
6747 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance5/6
Financial Health6/6
Dividends3/6

6747 Overview

Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region.

Price History & Performance

Summary of all time highs, changes and price drops for Brighten Optix
Historical stock prices
Current Share PriceNT$276.00
52 Week HighNT$127.50
52 Week LowNT$297.00
Beta0
1 Month Change4.55%
3 Month Change22.67%
1 Year Change77.49%
3 Year Changen/a
5 Year Changen/a
Change since IPO115.64%

Recent News & Updates

Apr 13
Tread With Caution Around Brighten Optix Corporation's (GTSM:6747) 2.0% Dividend Yield

Tread With Caution Around Brighten Optix Corporation's (GTSM:6747) 2.0% Dividend Yield

Could Brighten Optix Corporation ( GTSM:6747 ) be an attractive dividend share to own for the long haul? Investors are...

Shareholder Returns

6747TW Medical EquipmentTW Market
7D5.3%-0.6%-0.2%
1Y77.5%5.4%33.6%

Return vs Industry: 6747 exceeded the TW Medical Equipment industry which returned 5.4% over the past year.

Return vs Market: 6747 exceeded the TW Market which returned 33.6% over the past year.

Price Volatility

Is 6747's price volatile compared to industry and market?
6747 volatility
6747 Beta0
Industry Beta0.93
Market Beta1

Stable Share Price: 6747 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 6747's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/an/ahttps://www.brightenoptix.com.tw

Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable (GP) lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. It also provides OEM/ODM collaboration services.

Valuation

Is Brighten Optix undervalued compared to its fair value and its price relative to the market?

29.35x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 6747 (NT$276) is trading above our estimate of fair value (NT$258.66)

Significantly Below Fair Value: 6747 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 6747 is poor value based on its PE Ratio (29.4x) compared to the TW Medical Equipment industry average (22.8x).

PE vs Market: 6747 is poor value based on its PE Ratio (29.4x) compared to the TW market (16.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 6747's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 6747 is overvalued based on its PB Ratio (6.7x) compared to the TW Medical Equipment industry average (2.1x).


Future Growth

How is Brighten Optix forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

22.4%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 6747's forecast earnings growth is above the savings rate (0.8%).

Earnings vs Market: Insufficient data to determine if 6747's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 6747's revenue (22.4% per year) is forecast to grow faster than the TW market (9.5% per year).

High Growth Revenue: 6747's revenue (22.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6747's Return on Equity is forecast to be high in 3 years time (33.6%)


Past Performance

How has Brighten Optix performed over the past 5 years?

21.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 6747 has a large one-off gain of NT$100.2M impacting its June 30 2021 financial results.

Growing Profit Margin: 6747's current net profit margins (36.5%) are higher than last year (23.7%).


Past Earnings Growth Analysis

Earnings Trend: 6747's earnings have grown significantly by 21.4% per year over the past 5 years.

Accelerating Growth: 6747's earnings growth over the past year (96.7%) exceeds its 5-year average (21.4% per year).

Earnings vs Industry: 6747 earnings growth over the past year (96.7%) exceeded the Medical Equipment industry 9.5%.


Return on Equity

High ROE: 6747's Return on Equity (22.6%) is considered high.


Financial Health

How is Brighten Optix's financial position?


Financial Position Analysis

Short Term Liabilities: 6747's short term assets (NT$833.0M) exceed its short term liabilities (NT$234.4M).

Long Term Liabilities: 6747's short term assets (NT$833.0M) exceed its long term liabilities (NT$32.7M).


Debt to Equity History and Analysis

Debt Level: 6747 is debt free.

Reducing Debt: 6747 had no debt 5 years ago.

Debt Coverage: 6747 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 6747 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Brighten Optix current dividend yield, its reliability and sustainability?

1.95%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 6747's dividend (1.95%) is higher than the bottom 25% of dividend payers in the TW market (1.94%).

High Dividend: 6747's dividend (1.95%) is low compared to the top 25% of dividend payers in the TW market (5.25%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether 6747's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 6747's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (54.4%), 6747's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 6747's dividends in 3 years are forecast to be covered by earnings (79.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Brighten Optix has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10%.


Top Shareholders

Company Information

Brighten Optix Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Brighten Optix Corporation
  • Ticker: 6747
  • Exchange: TPEX
  • Founded: NaN
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: NT$6.507b
  • Shares outstanding: 24.19m
  • Website: https://www.brightenoptix.com.tw

Location

  • Brighten Optix Corporation
  • No.150, Chengde Road
  • 6F-1
  • Taipei City
  • 11167
  • Taiwan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/17 15:45
End of Day Share Price2021/09/17 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.